Head-to-head · WeighScore
24hrDOC vs Maves
The verdict
24hrDOC takes it — 72.1/100 to 71.8/100, but only just.
24hrDOC grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. 24hrDOC is a fast cash-pay telehealth service that prescribes compounded GLP-1 medications for weight loss, including once-weekly semaglutide injections, oral semaglutide tablets, and tirzepatide. Maves is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | 24hrDOC | Maves |
|---|---|---|
| WeighScore | 72.1/100 | 71.8/100 |
| Grade | C | C |
| Scorecard rank | #83 | #88 |
| Semaglutide | $149/mo (2 mg dose, compounded) | $99/mo (starting dose, first-month rate, compounded) |
| Tirzepatide | $239/mo (starting dose, compounded) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #83 · C
Strengths
- Low compounded semaglutide price, around 149 per month
- Fast model: 10-minute assessment, Rx within 45 minutes
- Injectable and oral semaglutide plus tirzepatide options
- 24/7 availability with unlimited provider messaging
Where it loses points
- Compounded only, not FDA-approved branded GLP-1s
- Self-pay only, no insurance accepted
- States served not disclosed on the site
- Fast-prescribing model offers less in-depth clinical workup
Graded #88 · C
Strengths
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
- All 50 states covered, stated explicitly
- Both brand (Maves) and parent (Homera Health) disclosed for accountability
Where it loses points
- 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
- Tirzepatide pricing not stated on the homepage — only listed as an offering
- Named medical director / clinical leadership not disclosed
- Refund and cancellation policy not detailed publicly
- Corporate address and arbitration venue not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.